| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |